Burkitt's lymphoma in Europe

Area of Science:

• Pediatric Oncology
• Hematology
• Cancer Genetics

Background:

• Burkitt's lymphoma (BL) is a common childhood non-Hodgkin's lymphoma in Europe.
• It presents with distinct age distribution and a male predominance.
• Epstein-Barr virus (EBV) is associated in 15% of cases.

Purpose of the Study:

• To define Burkitt's lymphoma characteristics.
• To outline treatment outcomes and prognosis.

Main Methods:

• Cytogenetic analysis (8;14 translocation) for diagnosis.
• Clinical presentation and staging.
• Chemotherapy response and survival rates.

Main Results:

• Abdominal masses are common (70%), jaw involvement is rare (4%).
• Complete remission is typically achieved with initial chemotherapy.
• Over 80% of BL cases are now curable with modern treatment.

Conclusions:

• BL is an aggressive but highly curable lymphoma.
• Prognosis is stage-dependent, with early stages showing excellent survival.
• Long-term cure is expected for most patients achieving remission.